Replies to post #72501 on Regen BioPharma Inc (RGBP)

[Big Eli]

End of July.

[Madguppy]

Earliest 2. August

[Skiluc]

I think we see 10k in July for 2020. And are SEC current By mid August.

My opinion, Since you asked. The Law would have a better grasp.

[raja48185]

FYI - saw this on Stocktwits (Seems he got it on his Ameritrade Account).

'Just got this. August 13th this will be restricted if it’s not pink current'.

https://stocktwits.com/Trickre167

[bjl]

2) August

[Fish finder]

Is it possible there bought out before all this has to transpire?

[aheadofthecurve]

Between now and my bday Aug 11.
#2

[Trish0949]

July

[rockie101]

OTCShotCaller...you wanting opinions then are you worried about the up coming due date ?

[AfricanTrader]

RGBP PINK CURRENT BY END OF JULY

10K for 2020 should take less time as opposed to 2019.

[Sat Naam]

if not the 1st week of august then the last week of september

[T-Money3000]

Hopefully before August 13, given the TD Ameritrade email we all just got.

[OTCShotCaller]

Thank You All Who Replied To My Request For Pink Current Opinions

My opinion is we will be Pink Current between the end of July to the end of August which is supported by the consensus of several of my direct colleagues.

Then in the wake of that happening (within 1-2 Weeks) I believe it is highly likely RGBP will be bought out by a Big Pharma similar to what happened to Kite Pharma that was bought out by Gilead in 2017 for $11.9 Billion in Cash.

Pre-Buy Out, Kite Pharma was a developmental stage Bio-Pharma in the same Market space as RGBP relative to their immunology based Patent(s) for treating various cancers.

At the time of their buy out, they had developed a Chimeric Antigen Receptor T-Cell Therapy (CAR-T) that harnesses the body’s immune cells to recognize and attack malignant cells. Sound familiar??

That Patent got FDA Approval and successfully passed through all stages of clinical trials (as expected with a 95% probability associated the FDA Approval itself as I previously discussed) and made it to Market as a therapeutic for cancer treatment including advanced lymphomas. At the time of the buy out Gilead's Market Value was $96 Billion.

Will history repeat itself??

This is an opinion ONLY and the later point of the Buy Out is supported by Koos filing the 8K that protects against a Hostile Take Over during buy out negotiations that most everyone here is likely well aware of by now.

Be well and prosper...